52,721名1型糖尿病青少年中乳糜泻患病率:三大洲国际比较
该研究分析了来自德国/奥地利、美国、英国和澳大利亚四个登记数据库的52,721名18岁以下1型糖尿病青少年,发现活检确诊乳糜泻患病率为3.5%,且在不同国家间差异显著(1.9%至7.7%)。合并乳糜泻的青少年诊断糖尿病年龄更小、身高SDS更低、超重/肥胖比例更低,但糖化血红蛋白水平无显著差异。
要点
- 52,721名1型糖尿病青少年中,活检确诊乳糜泻患病率为3.5%。
- 乳糜泻患病率在不同国家间差异显著,从1.9%至7.7%不等。
- 合并乳糜泻者身高SDS更低(0.36 vs 0.48),但糖化血红蛋白无显著差异。
核心结论
- 乳糜泻是1型糖尿病青少年常见的共病。
- 乳糜泻患病率的差异可能反映国际间筛查和诊断实践的不同和/或乳糜泻风险差异。
- 尽管血糖控制无差异,但较低的身高SDS支持对该人群进行生长和营养的密切监测。
研究设计与样本
- 数据来源为前瞻性糖尿病随访登记(DPV)(德国/奥地利)、T1D Exchange Clinic Network(T1DX)(美国)、National Paediatric Diabetes Audit(NPDA)(英国[英格兰/威尔士])和Australasian Diabetes Data Network(ADDN)(澳大利亚)。
- 分析纳入52,721名18岁以下、在2013年4月至2014年3月期间有门诊就诊的青少年。
- 构建多变量线性和逻辑回归模型,分析结局(HbA1c、身高SDS、超重/肥胖)与1型糖尿病/乳糜泻 versus 1型糖尿病的关系,并校正性别、年龄和糖尿病病程。
主要发现
- 活检确诊的乳糜泻存在于1,835名青少年中(3.5%),诊断中位年龄为8.1岁(四分位距5.3-11.2岁)。
- 乳糜泻诊断时糖尿病病程<1年者占37%,>1-2年者占18%,>3-5年者占23%,>5年者占17%。
- 乳糜泻患病率从T1DX的1.9%至ADDN的7.7%不等,女孩高于男孩(4.3% vs 2.7%,P < 0.001)。
- 合并乳糜泻者诊断糖尿病时年龄更小(5.4 vs 7.0岁,P < 0.001),非白人比例更低(15 vs 18%,P < 0.001)。
- 合并乳糜泻者身高SDS更低(0.36 vs 0.48,校正P < 0.001),超重/肥胖比例更低(34 vs 37%,校正P < 0.001),而平均HbA1c值相当:8.3 ± 1.5%(67 ± 17 mmol/mol) versus 8.4 ± 1.6%(68 ± 17 mmol/mol)。
临床怎么用
- 作者认为,较低的身高SDS支持对该人群进行生长和营养的密切监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Celiac disease (CD) has a recognized association with type 1 diabetes. We examined international differences in CD prevalence and clinical characteristics of youth with coexisting type 1 diabetes and CD versus type 1 diabetes only. RESEARCH DESIGN AND METHODS: Data sources were as follows: the Prospective Diabetes Follow-up Registry (DPV) (Germany/Austria); the T1D Exchange Clinic Network (T1DX) (U.S.); the National Paediatric Diabetes Audit (NPDA) (U.K. [England/Wales]); and the Australasian Diabetes Data Network (ADDN) (Australia). The analysis included 52,721 youths <18 years of age with a clinic visit between April 2013 and March 2014. Multivariable linear and logistic regression models were constructed to analyze the relationship between outcomes (HbA1c, height SD score [SDS], overweight/obesity) and type 1 diabetes/CD versus type 1 diabetes, adjusting for sex, age, and diabetes duration. RESULTS: Biopsy-confirmed CD was present in 1,835 youths (3.5%) and was diagnosed at a median age of 8.1 years (interquartile range 5.3-11.2 years). Diabetes duration at CD diagnosis was <1 year in 37% of youths, >1-2 years in 18% of youths, >3-5 years in 23% of youths, and >5 years in 17% of youths. CD prevalence ranged from 1.9% in the T1DX to 7.7% in the ADDN and was higher in girls than boys (4.3% vs. 2.7%, P < 0.001). Children with coexisting CD were younger at diabetes diagnosis compared with those with type 1 diabetes only (5.4 vs. 7.0 years of age, P < 0.001) and fewer were nonwhite (15 vs. 18%, P < 0.001). Height SDS was lower in those with CD (0.36 vs. 0.48, adjusted P < 0.001) and fewer were overweight/obese (34 vs. 37%, adjusted P < 0.001), whereas mean HbA1c values were comparable: 8.3 ± 1.5% (67 ± 17 mmol/mol) versus 8.4 ± 1.6% (68 ± 17 mmol/mol). CONCLUSIONS: CD is a common comorbidity in youth with type 1 diabetes. Differences in CD prevalence may reflect international variation in screening and diagnostic practices, and/or CD risk. Although glycemic control was not different, the lower height SDS supports close monitoring of growth and nutrition in this population.
引用
- Craig ME, Prinz N, Boyle CT, et al. Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents. Diabetes Care. 2017. PMID: 28546222. doi:10.2337/dc16-2508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。